Neu-Age Therapeutics
Manufacturing · 1-10 Employees
View Company Info for Free
Overview
Website
www.neuagetherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Neu-Age Therapeutics
Neu-Age Therapeutics focuses on developing pharmaceuticals aimed at preventing the progression of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis. The company addresses the common pathologies associated with these disorders, particularly the role of insoluble protein aggregates and mitochondrial dysfunction. Their mission is driven by the increasing prevalence of age-related neurodegenerative diseases and the need for innovative treatment approaches. Neu-Age Therapeutics is committed to reducing oxidative damage to neurons, ultimately improving the quality of life for affected individuals.Explore more
Popular SearchesNeu-Age Therapeutics LLCNeu-Age TherapeuticsNeuage Therapeutics LLCSIC Code 28,283NAICS Code 32,325Show more
Neu-Age Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neu-Age Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Neu-Age Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Neu-Age Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Neu-Age Therapeutics
Funding: Get notified immidiatlly once Neu-Age Therapeutics has new funding data
Neu-Age Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Neu-Age Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Neu-Age Therapeutics is spiking on competitors!
Product Launch: Get notified when Neu-Age Therapeutics launches new products
Recommended Actions
Find VP level buyers at Neu-Age Therapeutics
Find 3 more new buyers
Compare Similar Companies to Neu-Age Therapeutics
Compare insights from companies similar to Neu-Age Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neu-Age Therapeutics
<$5M
1-10
Private
-
2015
SW
Sheron Wylie-ModroCEO & Neuroscience Founder & Director
Company Profile Activity
Activity Insights
Neu-Age Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neu-Age Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neu-Age Therapeutics.
Neu-Age Therapeutics Tech Stack
A closer look at the technologies used by Neu-Age Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neu-Age Therapeutics
Sign Up For FreeTo access detailed company insights
Neu-Age Therapeutics focuses on developing pharmaceuticals aimed at preventing the progression of neurodegenerative diseases such as Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis. The company addresses the common pathologies associated with these disorders, particularly the role of insoluble protein aggregates and mitochondrial dysfun... Read More
